Clinical Trials Directory

Trials / Completed

CompletedNCT00926692

Investigations Regarding B-cell Subsets in Humans

Status
Completed
Phase
Study type
Observational
Enrollment
249 (actual)
Sponsor
Northwell Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The aim of this research is to define the human equivalent of mouse B1 cells.

Detailed description

The specific aim of this research project is to define the human equivalent of mouse B1 cells. This will be done by evaluating IgM secretion, surface markers, functional characteristics, V gene usage, N-region addition, and phosphorylation status of intracellular proteins, gene expression, sequencing of immunoglobulin genes, determination of antigenic specificity, replication history, and response to different stimuli. The goal of this project is to begin to the translation of decades of basic science research and research in the mouse model into the human system. It is believed that properly defining this B cell subset in humans will lead to better therapeutics, prognostics and prevention for a number of disease including infections, autoimmune disease, and cancer.

Conditions

Interventions

TypeNameDescription
OTHERBlood drawSubject will have blood draw.

Timeline

Start date
2009-04-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2009-06-23
Last updated
2015-08-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00926692. Inclusion in this directory is not an endorsement.